Vertex Pharmaceuticals is backed by CF dominance and JOURNAVX optionality, with key catalysts ahead for growth and upside.

Vertex Pharmaceuticals ( VRTX +0.01%) has been a top pharma stock in recent years. It has been generating strong revenue growth while also building out its portfolio of drugs, expanding its growth ...

Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

With a market cap of $101.6 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a leading U.S.-based biotechnology company ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Vertex Pharmaceuticals. Looking at options history for Vertex Pharmaceuticals (NASDAQ:VRTX) we detected 11 trades. If we ...

Vertex stock's valuation is now more attractive despite growth risks. Learn more about VERX's revenue trends, challenges, and future outlook.

Vertex AI is a comprehensive machine learning platform by Google Cloud, provides an all-inclusive suite of tools and resources for the creation, deployment, and customization of machine learning ...

Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The heritage British brand has been revived by a chairman whose impressive career before watchmaking includes a three-year stint with Elon Musk.

From kitchen appliances to air purifiers, Shark is a brand known for its cutting-edge products, including a wide range of vacuums. The brand’s stick vacuums, which include corded and cordless models, ...